Development status: Experimental

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Active against ESKAPE pathogens including arm, erm-, cfr- and lsaA-expressing strains; binds to the large ribosomal subunit interfering with translation initiation

Additional information: Synthetic compound (component based and structure guided design); non-haemolytic and non-toxic towards mammalian cell; bacteriostatic